Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Test to Revolutionize Disease Detection in People, Crops, and Stock

March 23, 2015 8:43 am | by University of Queensland | News | Comments

A single-drop DNA test invented by scientists could revolutionize the detection of diseases in humans, livestock and crops. Read more...


Novartis' Cosentyx Shows Sustained Effect and Favorable Safety Profile

March 23, 2015 8:35 am | News | Comments

Novartis announced new two-year results demonstrating strong and sustained efficacy with Cosentyx. Read more...


Biogen: Positive Phase 1 Results for Alzheimer's Drug

March 23, 2015 8:26 am | News | Comments

Treatment with the drug produced a dose and time dependent reduction of amyloid plaque in the brain. Read more...


New Hopes for Rheumatic Fever Vaccine

March 23, 2015 8:26 am | by University of Auckland | News | Comments

A new vaccine to combat the debilitating disease caused by rheumatic fever may soon become a reality, saving hundreds of thousands of deaths from preventable heart disease around the world each year. Read more...


Liberians Overcome Fear to Volunteer for Ebola Vaccine Trial

March 23, 2015 8:24 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial. Read more...


US Anti-Drugs Work in Colombia Uses Cancer-Linked Herbicide

March 23, 2015 8:24 am | by Joshua Goodman, Associated Press | News | Comments

New labeling on the world's most popular weed killer as a likely cause of cancer is raising more questions for an aerial spraying program in Colombia that underpins U.S.-financed efforts to wipe out cocaine crops. Read more...


Officials Urge Meningitis Shots at University of Oregon

March 20, 2015 10:16 am | by Jeff Barnard, Associated Press | News | Comments

More than half of the undergraduates at the University of Oregon have not been vaccinated against meningitis, despite the fact that one student has died and five others have been sickened since January. Read more...


New Hope for Beating Deadly Hereditary Stomach and Breast Cancers

March 20, 2015 10:11 am | by University of Otago | News | Comments

Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs. Read more...


NSAIDS and Cancer Risk

March 20, 2015 10:01 am | by Sue McGreevy, Harvard University | News | Comments

An analysis of genetic and lifestyle data from 10 large epidemiologic studies has confirmed that regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce the risk of colorectal cancer in most individuals. Read more...


FDA Panel Backs GSK Inhaler for Adults, Not Adolescents

March 20, 2015 9:47 am | by Matthew Perrone, AP Health Writer | News | Comments

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents. Read more...


Sanofi Announces Top-Line Results for Study of Lyxumia

March 19, 2015 4:32 pm | News | Comments

Full results will be presented at the American Diabetes Association 75th Scientific Sessions in Boston. Read more...


AstraZeneca, Daiichi Sankyo to Jointly Commercialize Movantik in U.S.

March 19, 2015 4:28 pm | News | Comments

Movantik is a first-in-class once-daily oral peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation. Read more...


World-First Cancer Drugs Could Work in Larger Group of Patients

March 19, 2015 4:22 pm | by Institute of Cancer Research | News | Comments

A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumors with another type of genetic fault. Read more...


AbbVie, C2N Enter Into License Agreement For Alzheimer's Therapy

March 19, 2015 4:17 pm | News | Comments

​AbbVie announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders. Read more....


Stem Cells Show Promise for Reversing Type 2 Diabetes

March 19, 2015 4:15 pm | by University of British Columbia | News | Comments

Scientists have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.